EML4 and neoplasm: The F-circEA-2a exists in the tumor, but not in the plasma of NSCLC patients with EML4-ALK fusion gene, further indicating that F-circEA has a significant diagnostic value for the diagnosis of EML4-ALK-positive NSCLC.